SUMMARY A new amplified enzyme linked immunosorbent assay (amplified ELISA) kit for detecting herpes simplex virus (HSV) antigen was evaluated. Duplicate swabs were taken from 180 patients with clinically suspected herpes lesions. Tests were performed on a direct swab extract and viral transport medium containing a swab.
Until recently the enzyme linked immunosorbent assay (ELISA) for the direct detection of herpes simplex virus (HSV) in clinical specimens was not very sensitive compared with conventional virus culture.`5
The ELISA, however, has advantages over virus culture regarding speed and ease of handling of specimens. This has become more important as an effective antiviral treatment, which has to be started as early as possible, is now available. An enzyme amplification system that increases the sensitivity of antigen detection has been incorporated into an ELISA for HSV. Clayton et al found that this recently developed enzyme amplified ELISA had greater absolute sensitivity than a conventional ELISA. 6 The purpose ofthis trial was to assess the sensitivity, specificity, reproducibility, and ease of use of this new enzyme amplified ELISA in a routine virological laboratory.
Patients and methods
We collected specimens from 180 patients attending sexually transmitted disease (STD) clinics in Amsterdam who had clinical indications of active HSV infections. Clinical data noted about the patients included sex, age, and site and type of lesion. Two specimens were taken from each patient, one with a dacron tipped plastic swab provided by the manufacturer and the other with a sterile wooden swab with cotton tip used routinely for virus culture by our laboratory. The culture swab was taken first in the first 82 patients, and the sequence was reversed in the last 98 patients. Ofthe first 82 patients, 31 had early lesions (vesicles) and 51 late lesions (ulcers). Of the last 98 patients 48 had vesicles and 50 ulcers. The ELISA swab was treated with 1 ml extraction fluid before testing by the amplified ELISA. The culture swab was put into 2 ml Hanks' transport medium (Hanks's TC (tissue culture), Difco 5774-72-6) 150 ml, sodium bicarbonate (Merck 6329) 0.5 g, penicillin 150 000 IU, streptomycin 150 mg, and distilled water 1100 ml) and used for tissue culture. An aliquot of the transport medium was frozen at -70°C and also tested by the amplified ELISA.
VIRUS CULTURE
Swabs collected in Hanks' transport medium were immediately stored at 4°C until inoculated on monolayer cultures of Vero cells. This was usually on the same day, but specimens arriving late in the afternoon were inoculated the next morning. Cells were examined three times a week for cytopathic effect for a maximum of two weeks. Typical cytopathic effect was confirmed by direct immunofluorescence using monoclonal antibodies specific to HSV types 1 and 2, which were labelled with a fluorescein isothiocyanate conjugate (Syva, USA).
ELISA PROCEDURE
We used an enzyme amplified immunoassay kit (Wellcome Research Laboratory, Kent, England), which contained test well strips coated with mouse monoclonal antibody to a common antigen type ofHSV and control well strips coated with mouse monoclonal antibody of unrelated specificity. The test procedure was as described by Clayton et al,6 using five controls (negative, weakly positive, strongly positive, negative Hanks' transport medium, and negative extraction buffer), except that we used 150 p1, rather than 50 p1, of each sample. The absorbance of each well was read at 492 nm. The cut offvalues for the transport medium and the extraction buffer were calculated for each run by subtracting the absorbance ofthe control well from the absorbance of the test well for the transport medium or the extraction buffer and adding 0 1.
NEUTRALISATION TEST
The presence or absence of HSV antigen in culture negative samples that were positive by ELISA was confirmed by neutralisation. The test sample (150 p1) was incubated in assay wells with 25 pl human serum containing HSV antibody or 25p1 seronegative human serum for two hours at room temperature, conjugate was added, and the ELISA performed. An appreciable (more than half) decrease in inhibition of reactivity with specific antibody confirmed the presence of HSV antigen.
Results
Of the 180 specimens tested, 93 were cell culture positive for HSV. Of the 93 culture positive lesions, 68 were positive by ELISA with both extraction buffer and transport medium, 10 were positive by ELISA with only extraction buffer, and four were positive with only transport medium. The table shows that, compared with culture, ELISA with extraction buffer was 83-9% (78/93) sensitive and 94.3% (82/87) specific, and with transport medium was 77-4% (72/ 93) sensitive and 96.6% (84/87) specific. Of five samples positive by ELISA with extraction buffer and We did not find a significant correlation between the time until cytopathic effect was visible and the stage of the lesion (mean time 3-4 days for vesicles, 3 .7 days for ulcers) or between cytopathic effect and the results of the ELISA with extraction buffer (mean time 3.5 days for positive results, 3*7 days for false negative results).
The ELISA with extraction buffer was more sensitive when the directly extracted swab was taken first; (90.7% v 74-4%; x2 = 3.36; 0.05 < p < 0 1). The sensitivity of the ELISA with transport medium did not vary with the sequence of sampling (76.9% v 77 8%). In all groups the specificity varied between 93 and 97 7% and did not depend on the sequence of sampling.
Of the 93 HSV positive cultures, 11 were HSV1 and 82 HSV2. Of the 11 HSV1 lesions, all were positive by ELISA with extraction buffer and nine by ELISA with transport medium.
Discussion
We compared a new amplified ELISA with cell culture for detecting HSV. Though the method was rapid and easy to perform and in our experience more sensitive than the conventional ELISA, the sensitivity was less than that of our Because it would be valuable if ELISA and cell culture could be undertaken from the same specimen sample, we also applied the ELISA to the transport medium. We found no differences in sensitivity between ELISA using transport medium and culture in relation to sequence ofsampling, probably because the same sample was used for both procedures. In contrast, two different samples were used for ELISA using extraction buffer. The overall lower sensitivity of the ELISA using transport medium (77.4%) may be explained by the greater dilution of virus antigen, as we used 2 ml transport medium for culture and 1 ml extraction fluid for the ELISA. Clayton et al also found a lower sensitivity of the ELISA with transport medium (78%) than with extraction buffer (92%). 6 Morgan et al found a decrease of 15% in antigen detection with another ELISA by using 3 ml transport medium instead of 2-2 ml. 3 The importance of the antigen load for the ELISA, as for culture, is also reflected in the stage of the lesion. In conclusion, this amplified ELISA gives better results than the conventional ELISA with clinical specimens and may be used when culture facilities are not easily available. It has the advantage of speed and simplicity, but cannot replace culture for screening of low prevalence groups. 
